UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	January 3, 2022 4:00 P.M.

Form:	S-3
CIK: 0001501697 Company Name: X4 Pharmaceuticals, Inc File Number: 333-261871